文献速递结核与非结核分枝杆菌

IFN-γ与TNF-α双释放荧光斑点试验诊断活动性结核

An IFN-γ and TNF-α dual release fluorospot assay for diagnosing active tuberculosis.
PubMed 文献 · Clin Microbiol Infect · 2019-11-13

该前瞻性研究纳入153例疑似结核成人患者,评估IFN-γ/TNF-α双释放荧光斑点试验诊断活动性结核的性能。双释放试验特异性94%,显著高于QuantiFERON-In-Tube的72%(p<0.001),敏感性84%与89%无显著差异(p=0.79)。提示该试验可能有助于鉴别活动性结核与潜伏感染。

要点

  • 双释放荧光斑点试验诊断活动性结核特异性94%,高于IGRA的72%。
  • 双释放试验敏感性84%,与IGRA的89%无显著差异。
  • 该试验或可弥补IGRA无法区分活动性结核与潜伏感染的不足。

核心结论

  • IFN-γ/TNF-α双释放荧光斑点试验是诊断活动性结核的简单有用检测。

研究设计与样本

  • 前瞻性纳入28个月内疑似结核成人患者(含近期结核暴露者),最终分析153例:活动性结核45例,非活动性结核108例(LTBI 38例,非LTBI 70例)。

主要发现

  • QuantiFERON-In-Tube诊断活动性结核的敏感性84%(95%CI 70-93),特异性70%(95%CI 61-79)。
  • 双释放荧光斑点试验特异性94%,显著高于单释放试验的72%(p<0.001)。
  • 双释放试验敏感性84%,与单释放试验89%相比无显著差异(p=0.79)。

关键数值与推荐

  • 确诊或很可能结核归为活动性结核;非活动性结核依据QuantiFERON-In-Tube结果分为伴LTBI与不伴LTBI。

临床怎么用

  • 在疑似活动性结核成人中,可采用IFN-γ/TNF-α双释放荧光斑点试验提高诊断特异性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Currently available interferon (IFN)-γ-release assays (IGRA) cannot discriminate active tuberculosis (TB) from latent TB infection (LTBI), and so have limited clinical utility for diagnosing active TB. Since numbers of tumour necrosis factor (TNF)-α-producing T cells are highly correlated with active TB, we hypothesized that detecting IFN-γ- and/or TNF-α-producing T cells would overcome this limitation of IGRA. This study evaluated the diagnostic performances of the IFN-γ and TNF-α dual release fluorospot assay for active TB. METHODS: Adult patients with suspected TB including recent TB exposers were prospectively enrolled over a 28-month period. In addition to the conventional IGRA test (i.e. QuantiFERON-In-Tube), a fluorospot assay for detecting IFN-γ- and TNF-α-producing T cells was performed. The final diagnoses were classified by clinical category. Patients with confirmed or probable TB were regarded as active TB, and patients with not active TB were further classified as having not active TB with and without LTBI, based on the QuantiFERON-In-Tube results. RESULTS: A total of 153 patients including 45 with active TB and 108 with not active TB (38 LTBI vs. 70 not LTBI) were finally analysed. The sensitivity and specificity of the QuantiFERON-In-Tube assay for active TB were 84% (95% confidence interval (CI), 70-93) and 70% (95% CI 61-79), respectively. The IFN-γ/TNF-α dual release assay by fluorospot had substantially higher diagnostic specificity (94%) for diagnosing active TB than the IFN-γ single release assay (72%, p < 0.001), without compromising sensitivity (84% vs. 89%, p 0.79). CONCLUSIONS: The fluorospot-based IFN-γ/TNF-α dual release assay appears to be a simple and useful test for diagnosing active TB.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Kim JY, Kang YA, Park JH, et al. An IFN-γ and TNF-α dual release fluorospot assay for diagnosing active tuberculosis. Clin Microbiol Infect. 2019. PMID: 31730906. doi:10.1016/j.cmi.2019.11.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。